The extraordinary improvement of patient outcome after surgical treatment for vestibular schwannomas is relatively recent and has occurred mainly over the last 30 years. The introduction of microsurgical techniques has resulted in increasing degrees of precise anatomical and functional preservation of the facial and cochlear nerves. An expanded microsurgical technique accompanied by continuous electrophysiological monitoring has resulted in marked changes in the primary goals for this surgery. Whereas in the past the primary goal of vestibular schwannoma management was to preserve the patient's life, the objective in vestibular schwannoma treatment today is to preserve neurological function.
The overall development of neurosurgery during the last century was accompanied by profound improvements in patient outcome after vestibular schwannoma surgery. Nevertheless, this history was also characterized by extreme and tragic difficulties, including high morbidity and mortality rates.
The achievements in vestibular schwannoma surgery were conspicuously marked by the following advances: 1) a better understanding of the microsurgical anatomy; 2) the current use of the operating microscope; and 3) the significant advances in neuroanesthesia, neurophysiology, and in standard operative techniques during the last 30 years. In this paper we provide an overview of the history of vestibular schwannoma treatment and the milestones that were achieved during this time. For the sake of consistency with historical works, we will often use the term "acoustic neuroma," although many now consider that term obsolete.
First Descriptions of Vestibular Schwannomas
As reported by Ahn, et al., 1 in 1777 Eduard Sandifort, a professor of anatomy in the Netherlands, described at autopsy the first unilateral acoustic tumor. Wishart 69 reported the first known case of bilateral acoustic neuromas in 1822: he described a patient who became progressively deaf in both ears, blind, had intractable vomiting and headaches, and facial twitching. The patient died at 21 years of age, and at autopsy Wishart found numerous tumors in the skull. Among these tumors, he described the following: "The seventh cranial nerve pair was diseased in the same manner; a tumor of the size of a small nut, and very hard, being attached to each of them, just where they enter the meatus auditorius internus." 69 Sir Charles Bell 10 (1774-1842) provided the first known report of a case of Meckel cave neuroma (a case diagnosed at autopsy) in 1833, demonstrating the relationship of the tumor to the cerebellopontine angle. Jean Cruveilhier 15 (1791-1874) was the first professor of pathological anatomy in Paris and he provided the first color illustrations of brain pathology in his atlas. 54 He described specimens of olfactory groove meningioma and a cerebellopontine angle tumor. As recounted by Pearce 54 and Spillane, 63 Cruveilhier attended a 26-year-old woman in the last 3 months of her life. Cruveilhier related that the onset of disease was with headaches and that the patient Evolution of vestibular schwannoma surgery: the long journey to current success lost her hearing at the age of 19 years. She became progressively blind, there were convulsive movements of the left side of her face, and "she got up every day" until the last month. At autopsy, Cruveilhier found a large tumor in the posterior fossa that was compressing the cerebellum and the brainstem, involvement of the fifth to 11th cranial nerves, and bilateral optic atrophy. The tumor was adherent to the back of the petrous bone and had eroded the internal auditory meatus.
Surgery of Cerebellopontine Angle Processes
The first reported case of successful surgery in the cerebellopontine angle (that is, in which the patient survived) was performed in 1894 by a British surgeon, Sir Charles Ballance (1856 Ballance ( -1936 . 8 Ballance popularized the operation of radical mastoidectomy for advanced middle ear infection in 1890 and he also demonstrated cranial base approaches to treat infectious thrombophlebitis of the petrosal, lateral, and cavernous sinus. 64 The patient treated by Ballance in 1894 was a 49-yearold woman who presented with headache, tinnitus, and vertigo that had lasted for 1 year. Six months before surgery she presented with right-sided hearing loss, vomiting, and progressive worsening of her overall condition. Ataxia and papilledema were additionally described. She underwent a posterior fossa craniectomy. Ballance described his findings as follows: "Solid tumor found attached to the dura over inner part of posterior surface of petrous. Somewhat firmly fixed, and the finger had to be insinuated between pons and tumor to get it away." 8 During the postoperative follow-up period the fifth and seventh cranial nerves were injured, and the right ulcerated eye had to be removed. The patient was still alive in 1907 but had persistent cranial nerve deficits. The pathological entity was reported as a fibrosarcoma; however, the neuromas were frequently described as gliosarcomas or fibrosarcomas at that time. 64 Some authors propose that Ballance actually could have removed a meningioma of the cerebellopontine angle, and not a neuroma. 3 In 1894, Ballance unsuccessfully attempted direct union of the facial nerve within the temporal bone. 64 In 1895, he was the first surgeon in the antiseptic era to perform a spinal accessory nerve-facial nerve anastomosis to treat facial palsy. 6, 7, 9, 64, 68 There were some problems related to such a technique, such as the occurrence of sternocleidomastoid and trapezius muscle paresis and atrophy, and the patients were unable to perform independent facial movements without associated movements of these two muscles as well. 6 Then, Ballance performed a hypoglossal nerve-facial nerve anastomosis in 1903 (an operation that had been performed for the first time by W. Korte of Germany in 1901), 64 with a more favorable outcome than the anastomosis with the accessory nerve. 7, 9 In 1913, Ballance further tried to develop the hypoglossal-facial nerve anastomosis technique, performing the procedure by joining the descending branch of the hypoglossal nerve to the distal hypoglossal nerve to minimize atrophy of the tongue. 64 At the National Hospital in London, in 1905, Horsley achieved total removal of an acoustic neuroma and the patient survived, but became severely disabled due to brainstem ischemia, which resulted from a lesion of the anterior inferior cerebellar artery. 67 In the same year, Borchardt performed the first transsigmoidal approach for resection of an acoustic neuroma, and in 1906 he reported his surgical results for cerebellopontine angle tumors, describing 18 cases that included 13 deaths. 13 An atlas of neurosurgery published by Fedor Krause (1857-1937) contains a detailed description of techniques used in the treatment of posterior fossa disease. 38 In 1898, he created a suboccipital osteoplastic craniotomy and cut the eighth cranial nerve to treat Ménière syndrome. Krause 39 reported that acoustic neuromas could be removed by surgery, and in his monograph (1909-1912) he described and illustrated his technique of removing tumors in the cerebellopontine angle by using a finger. Describing his results in cerebellopontine angle tumor resection, Krause reported 31 cases with 26 deaths. 37 At the International Congress of Medicine in London, Horsley, Eiselberg, and Krause reported mortality rates ranging from 67 to 84%. 18, 57 As related by Ahn, et al., 1 in 1903 an attempt was made by Garré to remove bilateral acoustic tumors that were found intraoperatively. Nevertheless, the patient died and the postmortem examination showed widespread neurofibromatosis.
Biggs described a case of bilateral acoustic neuromas and other intracranial tumors, as well as the results:
On November 19th Mr. McGavin reopened the wound ... the hemorrhage was only stopped after the application of forceps. The cerebellum bulged extensively into the wound, but no tumor could be felt or seen. The patient lost a considerable amount of blood and saline had to be administered per rectum. The wound was sutured and dressed, the forceps being left in situ, and the patient was sent back to the bed. On the 22nd Mr. McGavin, under chloroform, removed the forceps and plugging, but the hemorrhage was so severe that they had to be replaced.... The patient died at 2:30 AM on the 24th. 11 As related in Goodrich, 28 Thierry de Martel (1875-1940), a pioneer of French neurosurgery, had a special interest in tumors of the cerebellopontine angle. De Martel, who trained initially as an engineer, introduced the sitting position for posterior fossa surgery; previously there were descriptions of only the lateral or prone positions. With Joseph Babinski, who is known for describing the cutaneous plantar reflex, de Martel reported the case of a patient with a surgically treated acoustic neuroma who showed rapid clinical improvement. 5, 41 In 1916, Henschen 30 submitted a large clinical series, with 245 verified cases of unilateral and 24 bilateral acoustic neuromas, 19 of which were associated with neurofibromatosis. He discovered, by evaluating autopsy samples, that acoustic neuromas originate in the vestibular portion of the nerve lying in the porus acusticus. 1 Harvey Cushing (1869-1939), the father of American neurosurgery, together with Amory Codman, both trying to anticipate the changes in vital signs that led to death, 12 were the first to record the patient's intraoperative pulse, temperature, respiration, and ether dosage during anesthesia. 35 These innovations paved the way to enormous advances in the development of neuroanesthesia. Cushing developed the use of silver clips for hemostasis within the brain and later introduced the use of electrocautery in cerebral tumor operations. 22 In 1904, he presented his first reports on the surgeries in which monitoring of vital signs was used, but there were no survivors after craniotomy for tumors. 45 A. Koerbel, et al. 64 Cushing's pupil, Walter E. Dandy (1886 Dandy ( -1946 , did not accept the high rates of recurrence from acoustic neuromas reported by Cushing. Dandy 18 showed that acoustic neuromas could be resected in their totality, and might be associated with a lower mortality rate if, rather than a simple intracapsular removal, a capsular dissection was performed with meticulous techniques. In 1922, Dandy 17 published this strategy and technique and did not mention the earlier Cushing paper. As a result, Cushing sent a letter to the director of the hospital questioning Dandy's conduct. 28 In 1925, Dandy 18 described complete tumor removal in five patients in whom a bilateral suboccipital craniectomy was used, and later modified this to a unilateral craniectomy. In 1941 he reported a mortality rate of 10.87% after complete removal of 46 acoustic neuromas via a unilateral approach. 19 Nevertheless, he managed to preserve the facial nerve in only one of 45 surgically treated cases.
In 1921, Vilhelm Magnus (1871-1929) published his results in 31 patients who underwent operations for trigeminal neuralgia by a resection of the pontine nerve root or gasserian ganglion, with pain relief achieved in all but one. 46, 47 At the annual meeting of the Scandinavian Surgical Association in Copenhagen in 1925, he presented his results from the brain tumor surgery with the following remarks:
Brain surgery ... the mortality being horrific. Fedor Krause, for example, has a mortality of 50%, Küttner 45% and von Eiselsberg 40%. For operations such as extirpation of acoustic nerve tumors the mortality is over 80% ... in my opinion, this view is baseless defeatism, for Cushing has a mortality of 8,4% and I myself of 10,5%. The reason for Cushing and myself having so much lower a mortality than the surgeons named above is quite simple: the general surgeon does not have sufficient training, either theoretical or technical, for this demanding branch of surgery. 48 According to Fodstad, et al., 25 in 1926 Magnus declared that his surgical mortality rate in 161 patients with supratentorial tumors was 8%, whereas it was 17% in 55 patients with infratentorial tumors. There was only one death among 14 patients with acoustic neuromas.
After a 5-week visit to Cushing in 1928, Magnus reported the following about his host:
... He said that he considered operations for tumors of the acoustic nerve to be the most exacting ones he knew, and he had harsh judgment to pronounce on those surgeons who without the requisite experience undertook these operations, which in the hands of an inexperienced surgeon were desperate remedies indeed. ...
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As Shambaugh 62 relates, in 1935 Norman Dott of Edinburgh successfully inserted a long graft from the stump of the facial nerve near the brainstem at the stylomastoid foramen, following removal of an acoustic neuroma. In 1949, Horrax and Poppen 31 supported Dandy's philosophy, and reported the advantage of complete removal of acoustic neuromas. They cited a 5-year mortality rate of 12.7%, which was much lower than the 54 to 56% mortality rate associated with intracapsular decompression.
Herbert Olivecrona (1891-1980) graduated as a physician in Stockholm. At the age of 31 years, he performed surgery on his first brain tumor, in a patient who had a brain metastasis. 43 The tumor was not localized in the surgery and the patient died of massive swelling with herniation of brain tissue. His second patient, who had an acoustic neuroma, could not be adequately positioned, because the face was pointing down as required for the operation. Olivecrona mounted the head cap from a hairdryer of the kind (rafraicheur) used in beauty salons at that time, so that the patient's head could be supported face down. 43, 44 This surgical intervention took 6 hours and the patient survived only 18 days. Seventeen years later, in 1939, Olivecrona demonstrated that the facial nerve could be preserved in the surgical treatment of acoustic neuromas, with a rate of preservation of 65%, extraordinary results for that time. 28, 52, 57 He further described a series with 300 patients and 148 complete tumor removals. Facial function was preserved in 69 of these patients. 27 The mortality rate was similar in the groups with partial and total removal (~ 29%). Late follow-up reviews of Olivecrona's patients showed, however, that half of them either had a recurrence or died of one. 31, 58 Until 1964, the suboccipital approach was used in the vast majority of surgeries for acoustic neuromas. 57 In the 1960s, the use of steroid drugs was introduced to reduce cerebral edema. 4 
Development of Microsurgery and the Modern Management of Vestibular Schwannomas
In 1904, Panse 53 demonstrated the translabyrinthine approach, which was then not used for the next 60 years. 57 In the 1960s, House developed the middle fossa approach and applied it to acoustic neuromas and other diseases of the internal auditory canal. 32, 33 He realized, however, the limited exposure provided by this approach and further developed new options for approaching tumors of the cerebellopontine angle. House had observed the use of an operating microscope in otorhinolaryngology surgeries performed by Wülstein in Germany (L Osterwald, personal communication). House applied the microscope and microsurgical techniques to the translabyrinthine approach, becoming adept at preserving the facial nerve at excellent rates for that era and reducing the operative mortality rate. 20, 57 The otolaryngologists were the first to use the operating microscope in clinical surgery, followed by ophthalmologists, vascular surgeons, and plastic surgeons, who started to use the microscope in the operating room after World War II. 40 In 1957, at the University of Southern California, Theodore Kurze used an operating microscope for the first
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History of vestibular schwannoma surgery time in neurosurgery. In this landmark operation, Kurze removed a neurilemmoma of the seventh cranial nerve in a 5-year-old patient. In 1960, he established the world's first cranial base microsurgical laboratory.
In 1965, Rand and Kurze 55, 56 reported suboccipital transmeatal microdissection to remove acoustic tumors totally, affording the possibility of preservation of the facial, vestibular, and cochlear nerves. The suboccipital approach could potentially preserve the auditory function, which would not be possible via the translabyrinthine approach.
Leksell 42 described stereotactic radiosurgery in 1951 as a method to destroy intracranial targets by using single high doses of focused ionizing radiation, controlled by stereotactic guidance. As Niranjan and Lunsford 51 recount, in Stockholm in 1967, Leksell and E. O. Backlund performed the first gamma knife procedure, and 2 years later, in 1969, Leksell and G. Norén performed the first radiosurgery to treat an acoustic neuroma. Recent series reporting long-term outcomes in patients with acoustic neuromas who were treated radiosurgically show a high rate of facial and cochlear nerve preservation, along with long-term tumor control. 26, 36 Mahmut Gazi Yaşargil, a young Turkish neurosurgeon, returned to Zürich after completing a year of microsurgical training in Vermont and successfully performed the first superficial temporal artery-middle cerebral artery bypass in 1967. 21 Yaşargil was influenced by the ideas of Kurze and others to make microsurgery a fundamental part of modern neurosurgery, thus dramatically transforming how neurosurgical procedures were done. 2, 24, 40 He created innovative instrumentation, such as the floating microscope, the self-retaining adjustable retractor, and microsurgical instruments. 66 The development of computerized tomography, magnetic resonance imaging, and other imaging modalities, along with the introduction of neuromonitoring, all of which were associated with the aforementioned achievements in neurosurgery, allowed significant reductions in the morbidity accompanying cerebellopontine angle surgery. Several authors have recently reported increasing rates of facial and hearing preservation, associated with minimal mortality rates. 14, 23, 29, 60, 61 In 1999, Yaşargil, in his article containing professional memories, wrote:
... Professor Samii had already trained in microsurgical dissection and repair of injured peripheral nerves with Professor Millesi in Vienna, Austria. He immediately recognized the capabilities of microtechniques and could envision their potential in neurosurgery. Initially, he entered the field of the cerebellopontine schwannoma, and in the following 30 years, he succeeded in mastering a world record achievement in schwannoma surgery. I had my first opportunity to visit Hannover and observe his professional activities in the summer of 1997, when he operated on two vestibular schwannomas. I recognized the importance of laboratory training for the dissection and repair of peripheral nerves. I had discovered a double arachnoid membrane enveloping schwannomas in the CPA [cerebellopontine angle] and developed techniques confining dissection between these layers to preserve brainstem, arteries, and basal nerves, particularly the facial, cochlear, and vestibular group. In general, there were good postoperative outcomes in 450 patients, and the results have been published in Microneurosurgery, volume IVB. In spite of this success, I have always been under great tension and in a state of high anxiety during the entire surgical procedure of a schwannoma, owing to my great respect for dissection of the cranial nerves. It was a joy, therefore, to witness that Madjid Samii remained totally relaxed and placid because he knew how to guide his manipulations with the nerve to promote dissection.... 70 At that time, analysis of large series of patients showed rates of anatomical facial preservation of approximately 93%, rates of hearing preservation of 39 to 47%, and minimal mortality rates (1%) in vestibular schwannoma resection. [59] [60] [61] More recently, improved rates of hearing preservation have been achieved. Fifty-four percent of patients may attain preservation of their auditory function, with excellent results in small tumors (up to 71% of cases) and with relevant numbers and at satisfactory quality levels even in large tumors. 50 In a recent analysis (in 2004) of Professor Samii's last 200 vestibular schwannoma operations, facial nerve preservation was possible in 100% of the cases in Class T1 to T3 tumors (small lesions) and 97% in Class T4 tumors (large lesions). The rates of hearing preservation were still improving and there were no deaths (unpublished data).
Although there have been major improvements in the prevention of deafness by function-conserving microsurgery, there is no alternative treatment option when the auditory nerve has lost its function, either because of surgery or tumor growth. Bilateral vestibular schwannomas typically occur in patients suffering from neurofibromatosis Type 2. When bilateral deafness occurs in these patients, standard hearing aids and prostheses (like cochlear implants) are not effective. Since 1979, House and Hitselberger 34 have shown that patients with bilateral deafness due to neurofibromatosis Type 2 can benefit from auditory sensation provided by auditory brainstem implants. These devices bypass both the cochlea and the eighth cranial nerve and directly stimulate neurons of the central auditory pathway. Since this pioneering work, almost 300 profoundly deaf patients have received an auditory brainstem implant for partial restoration of hearing function.
More recently, experimental studies 65 have been performed to investigate biological regeneration of injured auditory nerves. In general, injury to the human and mammalian auditory nerve is associated with a lack of longdistance elongation and leads to definitive loss of the hearing function. To overcome this typical lack of functional regeneration in the central nervous system, a combined neurotrophic and antiinhibitory treatment is applied in experimental animal models. Intrathecal treatment with antibodies directed against myelin-associated neurite growth inhibitory proteins promotes significant elongation of the injured fibers of cochlear nerves. These regenerating fibers seem to navigate to the correct targets, and are able to establish synaptic connections for functional recovery. These findings may lead to future clinical applications for the regeneration of cochlear nerves.
Although the treatment protocol for vestibular schwannomas has improved significantly over the years, further improvements for the management of these lesions can and will certainly be achieved in the near future. The current and future achievements were made possible by the contributions of the noteworthy and industrious clinicians presented in this article.
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